Premium
An open‐label cluster‐randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID‐19 (ARCHAIC)—Protocol publication
Author(s) -
Weehuizen Jesper M.,
Hoepelman Andy I. M.
Publication year - 2020
Publication title -
european journal of clinical investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 107
eISSN - 1365-2362
pISSN - 0014-2972
DOI - 10.1111/eci.13297
Subject(s) - hydroxychloroquine , chloroquine , medicine , tolerability , viral load , clinical trial , population , antiviral drug , pharmacology , drug , covid-19 , intensive care medicine , virus , immunology , adverse effect , disease , infectious disease (medical specialty) , malaria , environmental health